Literature DB >> 25870246

Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding.

Kazuharu Kukita1, Yasuaki Tamura2, Tsutomu Tanaka3, Toshimitsu Kajiwara3, Goro Kutomi4, Keita Saito4, Koichi Okuya4, Akari Takaya3, Takayuki Kanaseki3, Tomohide Tsukahara3, Yoshihiko Hirohashi3, Toshihiko Torigoe3, Tomohisa Furuhata4, Koichi Hirata4, Noriyuki Sato3.   

Abstract

ERO1-α is an oxidizing enzyme that exists in the endoplasmic reticulum and is induced under hypoxia. It reoxidizes the reduced form of protein disulfide isomerase that has oxidized target proteins. We found that ERO1-α is overexpressed in a variety of tumor types. MHC class I H chain (HC) has two disulfide bonds in the α2 and α3 domains. MHC class I HC folding is linked to the assembly of MHC class I molecules because only fully disulfide-bonded class I HCs efficiently assemble with β2-microglobulin. In this study, we show that ERO1-α associates with protein disulfide isomerase, calnexin, and immature MHC class I before being incorporated into the TAP-1-associated peptide-loading complex. Importantly, ERO1-α regulates the redox state as well as cell surface expression of MHC class I, leading to alteration of susceptibility by CD8(+) T cells. Similarly, the ERO1-α expression within cancer cells was associated with the expression level of MHC class I in colon cancer tissues. Thus, the cancer-associated ERO1-α regulates the expression of the MHC class I molecule via oxidative folding.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25870246     DOI: 10.4049/jimmunol.1303228

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Secretory kinase Fam20C tunes endoplasmic reticulum redox state via phosphorylation of Ero1α.

Authors:  Jianchao Zhang; Qinyu Zhu; Xi'e Wang; Jiaojiao Yu; Xinxin Chen; Jifeng Wang; Xi Wang; Junyu Xiao; Chih-Chen Wang; Lei Wang
Journal:  EMBO J       Date:  2018-06-01       Impact factor: 11.598

2.  Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid.

Authors:  Claudia Lennicke; Jette Rahn; Jürgen Bukur; Falko Hochgräfe; Ludger A Wessjohann; Rudolf Lichtenfels; Barbara Seliger
Journal:  Oncoimmunology       Date:  2016-12-21       Impact factor: 8.110

Review 3.  Role of the ERO1-PDI interaction in oxidative protein folding and disease.

Authors:  Andrea G Shergalis; Shuai Hu; Armand Bankhead; Nouri Neamati
Journal:  Pharmacol Ther       Date:  2020-03-20       Impact factor: 12.310

4.  Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level.

Authors:  Tsutomu Tanaka; Goro Kutomi; Toshimitsu Kajiwara; Kazuharu Kukita; Vitaly Kochin; Takayuki Kanaseki; Tomohide Tsukahara; Yoshihiko Hirohashi; Toshihiko Torigoe; Yoshiharu Okamoto; Koichi Hirata; Noriyuki Sato; Yasuaki Tamura
Journal:  Br J Cancer       Date:  2016-04-21       Impact factor: 7.640

5.  Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells.

Authors:  Norio Takei; Akihiro Yoneda; Kaori Sakai-Sawada; Marina Kosaka; Kenjiro Minomi; Yasuaki Tamura
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

6.  Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer.

Authors:  Tsutomu Tanaka; Goro Kutomi; Toshimitsu Kajiwara; Kazuharu Kukita; Vitaly Kochin; Takayuki Kanaseki; Tomohide Tsukahara; Yoshihiko Hirohashi; Toshihiko Torigoe; Yoshiharu Okamoto; Koichi Hirata; Noriyuki Sato; Yasuaki Tamura
Journal:  Oncotarget       Date:  2017-04-11

7.  High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrence.

Authors:  Toshio Sakatani; Keita Maemura; Noriko Hiyama; Yosuke Amano; Kousuke Watanabe; Hidenori Kage; Masashi Fukayama; Jun Nakajima; Yutaka Yatomi; Takahide Nagase; Daiya Takai
Journal:  Jpn J Clin Oncol       Date:  2017-06-01       Impact factor: 3.019

Review 8.  Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology.

Authors:  Olga A Smirnova; Birke Bartosch; Natalia F Zakirova; Sergey N Kochetkov; Alexander V Ivanov
Journal:  Int J Mol Sci       Date:  2018-04-17       Impact factor: 5.923

Review 9.  ERO1-PDI Redox Signaling in Health and Disease.

Authors:  Vishwanath Jha; Tripti Kumari; Vijayprakash Manickam; Zahra Assar; Kirk L Olson; Jeong-Ki Min; Jaehyung Cho
Journal:  Antioxid Redox Signal       Date:  2021-07-13       Impact factor: 8.401

10.  Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.

Authors:  Hongzhe Li; Xinjing Wang; Yuan Fang; Zhen Huo; Xiongxiong Lu; Xi Zhan; Xiaxin Deng; Chenghong Peng; Baiyong Shen
Journal:  Oncotarget       Date:  2017-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.